Importantly, impairment of SG assembly via Ataxin-2 depletion and chemical inhibitors of eIF2α phosphorylation can suppress nucleocytoplasmic trafficking defects and C9ORF72 ALS models of neurodegeneration [55]. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.